Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141127 |
| CAS No | NA |
| Mol.F. | C8H8ClN3O2 |
| Mol.Wt. | 213.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141128 |
| CAS No | NA |
| Mol.F. | C17H15BrFN5O2 |
| Mol.Wt. | 420.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141129 |
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141130 |
| CAS No | NA |
| Mol.F. | C16H21N7O2 |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141131 |
| CAS No | NA |
| Mol.F. | C10H16N4O2 |
| Mol.Wt. | 224.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141132 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141133 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141134 |
| CAS No | NA |
| Mol.F. | C7H14N4O2 |
| Mol.Wt. | 186.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141135 |
| CAS No | NA |
| Mol.F. | C13H18N6O |
| Mol.Wt. | 274.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141136 |
| CAS No | NA |
| Mol.F. | C20H24N6O |
| Mol.Wt. | 364.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141137 |
| CAS No | NA |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141138 |
| CAS No | NA |
| Mol.F. | C15H17N7O2 |
| Mol.Wt. | 327.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141139 |
| CAS No | NA |
| Mol.F. | C16H19N7O2 |
| Mol.Wt. | 341.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141140 |
| CAS No | NA |
| Mol.F. | C17H20N6O2 |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141141 |
| CAS No | NA |
| Mol.F. | C6H7F3N6O3 |
| Mol.Wt. | 268.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141142 |
| CAS No | NA |
| Mol.F. | C39H44N8O6 |
| Mol.Wt. | 720.8 |
| INV STATUS | CUSTOM SYNTHESIS |